Q4 2024 Earnings Call Transcript February 12, 2025 CVS Health Corporation beats earnings expectations. Reported EPS is $1.19, ...

Q4 2024 Earnings Conference Call February 21, 2025 4:00 AM ETCompany ParticipantsThomas Hasler - Chief Executive OfficerAdrian ...

Operator Good morning, and thank you all for attending the CVS Health Q4 2024 earnings conference call. My name is Brika, and I will be your moderator for today's call. [Operator instructions] I would ...

It’s time to level the playing field, empower patients, and protect access both to medicines and to our local pharmacies. Let’s work together to bring accountability and transparency to drug pricing ...

The PBM system intentionally blocks lower-cost, FDA-approved biosimilars from being available to patients. Biosimilars are the commonsense, bipartisan solution to out-of-control prescription drug ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

New federal legislation would regulate an industry that’s been examined by FactFinder. Senator Jerry Moran, R-Kan., is one of the sponsors of the bipartisan bill addressing drug costs and transparency ...

Kathy Hochul, Bloomberg Law tells us. Lawmakers and pharmacists said the proposal for the state budget due on April 1 would push boundaries for transparency requirements on PBMs, the companies ...

Pharmacy benefit management giant Express Scripts unveiled several steps it's taking to boost transparency and mitigate high costs members may face. The PBM said in an announcement that about 80% ...

In the latest executive shakeup at CVS, the pharmacy giant has named a new president of its pharmacy benefit management ...